Search - tctmd.com

Displaying 241 - 259 of 259

Sort: Relevancy | Date

News Conference News

CRISP AMI: Balloon Pump Therapy Fails to Help STEMI Patients Without Shock

September 06, 2011

The Role of Atrial Shunts in the Treatment of HFpEF

CME

The Role of Atrial Shunts in the Treatment of HFpEF

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

CME

Treatment of Severe Aortic Stenosis: Why Wait for Symptoms?

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

CME

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

Managing the Growing Epidemic of HF: The Potential Role of Shunts

CME

Managing the Growing Epidemic of HF: The Potential Role of Shunts

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty & Chordal Repair

CME

Latest in Transcatheter Repair Therapies for Mitral Regurgitation: TEER, Annuloplasty& Chordal Repair TCT 2022

Optimizing the Duration of DAPT following PCI

CME

Optimizing the Duration of DAPT following PCI

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

Contrast-Induced Acute Kidney Injury: Preventive Measures that Work in High Risk Patients - Osprey/Abiomed

Partner Content

Contrast-Induced Acute Kidney Injury: Preventive Measures that Work in High Risk Patients - Osprey/Abiomed

November 12, 2019

Treating the Complex Patients: Impella-Enabled Complete Revascularization - Abiomed

Partner Content

Treating the Complex Patients: Impella-Enabled Complete Revascularization - Abiomed

November 12, 2019

Updates on Onyx ONE

CME

Updates on Onyx ONE

Evaluating the Heart Failure Patient with MR: Integrating Train Data Into Clinical Practice

CME

Evaluating the Heart Failure Patient with MR: Integrating Data Into Clinical Practice

Updates on TAVR in Low-Risk Patients

CME

Updates on TAVR in Low-Risk Patients

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Emerging Indications for TAVR

CME

Emerging Indications for TAVR

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

CME

TAVR-Moving to Low Risk: New Devices/Strategies to Reduce Complications

Key Design Criteria For True Next Generation DES

CME

Key Design Criteria For True Next Generation DES

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.